22nd Century Free Cash Flow 2012-2026 | XXII
22nd Century free cash flow from 2012 to 2026. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| 22nd Century Annual Free Cash Flow | |
|---|---|
| 2025 | -7.01 |
| 2024 | -14.46 |
| 2023 | -59.36 |
| 2022 | -54.96 |
| 2021 | -23.58 |
| 2020 | -15.67 |
| 2019 | -14.95 |
| 2018 | -18.29 |
| 2017 | -13.23 |
| 2016 | -10.09 |
| 2015 | -7.36 |
| 2014 | -6.16 |
| 2013 | 0.40 |
| 2012 | -1.76 |
| 2011 | -3.46 |
| 22nd Century Quarterly Free Cash Flow | |
|---|---|
| 2026-06-30 | -7.46 |
| 2026-03-31 | -3.14 |
| 2025-12-31 | -7.01 |
| 2025-09-30 | -9.75 |
| 2025-06-30 | -5.72 |
| 2025-03-31 | -2.99 |
| 2024-12-31 | -14.46 |
| 2024-09-30 | -10.07 |
| 2024-06-30 | -7.02 |
| 2024-03-31 | -2.24 |
| 2023-12-31 | -59.36 |
| 2023-09-30 | -53.88 |
| 2023-06-30 | -39.84 |
| 2023-03-31 | -19.21 |
| 2022-12-31 | -54.96 |
| 2022-09-30 | -35.15 |
| 2022-06-30 | -20.93 |
| 2022-03-31 | -8.19 |
| 2021-12-31 | -23.58 |
| 2021-09-30 | -18.68 |
| 2021-06-30 | -12.66 |
| 2021-03-31 | -4.01 |
| 2020-12-31 | -15.67 |
| 2020-09-30 | -12.66 |
| 2020-06-30 | -11.52 |
| 2020-03-31 | -4.67 |
| 2019-12-31 | -14.95 |
| 2019-09-30 | -12.03 |
| 2019-06-30 | -8.98 |
| 2019-03-31 | -4.64 |
| 2018-12-31 | -18.29 |
| 2018-09-30 | -12.93 |
| 2018-06-30 | -8.69 |
| 2018-03-31 | -3.32 |
| 2017-12-31 | -13.23 |
| 2017-09-30 | -10.51 |
| 2017-06-30 | -7.07 |
| 2017-03-31 | -2.71 |
| 2016-12-31 | -10.09 |
| 2016-09-30 | -8.11 |
| 2016-06-30 | -5.91 |
| 2016-03-31 | -2.80 |
| 2015-12-31 | -7.36 |
| 2015-09-30 | -4.89 |
| 2015-06-30 | -3.61 |
| 2015-03-31 | -2.52 |
| 2014-12-31 | -6.16 |
| 2014-09-30 | -3.34 |
| 2014-06-30 | -1.73 |
| 2014-03-31 | -0.54 |
| 2013-12-31 | 0.40 |
| 2013-09-30 | -2.45 |
| 2013-06-30 | -1.52 |
| 2013-03-31 | -1.15 |
| 2012-12-31 | -1.76 |
| 2012-09-30 | -1.30 |
| 2012-06-30 | -1.03 |
| 2012-03-31 | -0.28 |
| 2011-12-31 | -3.46 |
| 2011-09-30 | -2.48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Consumer Staples | Tobacco Products | $0.001B | $0.018B |
| 22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Philip Morris (PM) | United States | $293.986B | 23.29 |
| Altria (MO) | United States | $116.081B | 12.53 |
| British American Tobacco (BTI) | United Kingdom | $113.338B | 0.00 |
| JAPAN TOB (JAPAY) | Japan | $77.798B | 24.08 |
| Imperial Tobacco Group (IMBBY) | United Kingdom | $25.484B | 0.00 |
| Turning Point Brands (TPB) | United States | $1.320B | 29.24 |
| Universal (UVV) | United States | $1.099B | 21.32 |
| Air Global (AIIR) | United States | $0.297B | 0.00 |
| Ispire Technology (ISPR) | United States | $0.076B | 0.00 |